Integra Therapeutics to present ex vivo and in vivo data for its FiCAT gene writing platform at Advanced Therapies Europe congress

Advanced Therapies Europe - Avencia Sánchez Mejías

Integra Therapeutics will present positive data from ex vivo and in vivo preclinical studies that demonstrates the potential of its FiCAT gene writing platform for developing advanced therapies in the field of paediatric hepatology at the Advanced Therapies Europe congress, taking place in Estoril (Portugal) from 5 to 7 September. Dr Avencia Sánchez-Mejías, CEO and […]